From: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in-vitro study
30 s
60 s
90 s
120 s
180 s
Sig vs. Control
> 0.9999
0.0108
< 0.0001
Sig vs 30 s
0.0823
Sig vs 60 s
Sig vs 90 s
0.0259
Sig vs 120 s
0.1623